Fludarabine in the treatment of lymphoproliferative malignancies.
Feldman
E J
EJ
Department of Hematology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
Keating
M J
MJ
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D016393:Lymphoma, B-Cell / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D016399:Lymphoma, T-Cell / Q000188:drug therapy; D008232:Lymphoproliferative Disorders / Q000188:drug therapy; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine